122 related articles for article (PubMed ID: 23148625)
61. Expression and secretion of endostatin in thyroid cancer.
Hoffmann S; Wunderlich A; Lingelbach S; Musholt PB; Musholt TJ; von Wasielewski R; Zielke A
Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
[TBL] [Abstract][Full Text] [Related]
62. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel I; Schröder C; Müller V; Zander H; Tachezy M; Ihnen M; Jänicke F; Milde-Langosch K
Oncology; 2012; 82(6):305-12. PubMed ID: 22555284
[TBL] [Abstract][Full Text] [Related]
63. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
64. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
[TBL] [Abstract][Full Text] [Related]
65. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.
Kahlert C; Weber H; Mogler C; Bergmann F; Schirmacher P; Kenngott HG; Matterne U; Mollberg N; Rahbari NN; Hinz U; Koch M; Aigner M; Weitz J
Br J Cancer; 2009 Aug; 101(3):457-64. PubMed ID: 19603023
[TBL] [Abstract][Full Text] [Related]
66. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
67. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
von Lersner A; Droesen L; Zijlstra A
Clin Exp Metastasis; 2019 Apr; 36(2):87-95. PubMed ID: 30778704
[TBL] [Abstract][Full Text] [Related]
68. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
69. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.
Riemann B; Krämer JA; Schmid KW; Dralle H; Dietlein M; Schicha H; Sauerland C; Frankewitsch T; Schober O;
Nuklearmedizin; 2010; 49(3):79-84. PubMed ID: 20505894
[TBL] [Abstract][Full Text] [Related]
70. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
71. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
72. Isolation of cardiac cells from E8.5 yolk sac by ALCAM (CD166) expression.
Murakami Y; Hirata H; Miyamoto Y; Nagahashi A; Sawa Y; Jakt M; Asahara T; Kawamata S
Mech Dev; 2007; 124(11-12):830-9. PubMed ID: 17964124
[TBL] [Abstract][Full Text] [Related]
73. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
[TBL] [Abstract][Full Text] [Related]
74. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system.
Cayrol R; Wosik K; Berard JL; Dodelet-Devillers A; Ifergan I; Kebir H; Haqqani AS; Kreymborg K; Krug S; Moumdjian R; Bouthillier A; Becher B; Arbour N; David S; Stanimirovic D; Prat A
Nat Immunol; 2008 Feb; 9(2):137-45. PubMed ID: 18157132
[TBL] [Abstract][Full Text] [Related]
75. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract][Full Text] [Related]
76. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
[TBL] [Abstract][Full Text] [Related]
77. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
Minner S; Kraetzig F; Tachezy M; Kilic E; Graefen M; Wilczak W; Bokemeyer C; Huland H; Sauter G; Schlomm T
Hum Pathol; 2011 Dec; 42(12):1946-52. PubMed ID: 21683980
[TBL] [Abstract][Full Text] [Related]
78. ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium.
Münsterberg J; Loreth D; Brylka L; Werner S; Karbanova J; Gandrass M; Schneegans S; Besler K; Hamester F; Robador JR; Bauer AT; Schneider SW; Wrage M; Lamszus K; Matschke J; Vashist Y; Uzunoglu G; Steurer S; Horst AK; Oliveira-Ferrer L; Glatzel M; Schinke T; Corbeil D; Pantel K; Maire C; Wikman H
Neuro Oncol; 2020 Jul; 22(7):955-966. PubMed ID: 32064501
[TBL] [Abstract][Full Text] [Related]
79. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination.
Sanders AJ; Owen S; Morgan LD; Ruge F; Collins RJ; Ye L; Mason MD; Jiang WG
Oncotarget; 2019 Oct; 10(59):6362-6377. PubMed ID: 31695844
[TBL] [Abstract][Full Text] [Related]
80. Activated leukocyte cell adhesion molecule: a new paradox in cancer.
Ofori-Acquah SF; King JA
Transl Res; 2008 Mar; 151(3):122-8. PubMed ID: 18279810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
